George Demetri, Director at Blueprint Medicines Corp (BPMC), bought 2,610 shares at $82.66 ($827) on 2021-07-13, disclosed to the SEC on 2022-06-30.
Seasonal purchase ($827) by Director — this insider has traded BPMC in July in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.66 | 10 | $827 | 100.0% |
| 2 | $0.00 | 2,600 | $0 | 0.0% |
| Total | $0.32 avg | 2,610 | $827 | 100% |
| Filing → |
| BPMC | SELL | 2020-01-14 | $48K | — | Filing → |
| BPMC | SELL | 2020-01-09 | $275K | — | Filing → |
| BPMC | SELL | 2019-06-19 | $167K | — | Filing → |